rosiglitazone has been researched along with Diabetic Retinopathy in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 11 (57.89) | 29.6817 |
| 2010's | 5 (26.32) | 24.3611 |
| 2020's | 3 (15.79) | 2.80 |
| Authors | Studies |
|---|---|
| Bourne, PC; Dou, X; Duerfeldt, AS; Ma, JX; Nath, D; Nurmemmedov, E; Shin, H | 1 |
| Bacha, F; Braffett, BH; Gidding, SS; Gubitosi-Klug, RA; Levitt Katz, LE; Shah, AS; Shah, RD; Tryggestad, JB; Urbina, EM | 1 |
| Feng, Z; Wu, S; Xia, Z; Yang, X; Yi, G; Zheng, Y | 1 |
| Al Shaar, L; Azar, S; Bashshur, ZF; El-Mollayess, GM; Salti, HI | 1 |
| Aiello, LP; Child, A; Folkman, J; Shen, LQ; Weber, GM | 1 |
| Beare, N; Broadbent, DM; Kumar, N; Liazos, E | 1 |
| Kumar, H; Mishra, M; Tripathi, K; Vijay, SK | 1 |
| Contreras, R; Fong, DS | 1 |
| Bashir, M; Iqbal, M; Khan, R; Malik, SA | 1 |
| Cheng, L; Han, X; Shi, Y | 1 |
| Higuchi, A; Ohashi, K; Ouchi, N; Shibata, R; Sono-Romanelli, S; Walsh, K | 1 |
| Chu, SH; Chun, SH; Li, AH | 1 |
| Guagnini, AP; Hautenauven, F; Lekeu Hinostroza, JP; Nyssen, V | 1 |
| Li, P; Liu, K; Shi, Y; Xu, X; Zheng, Z; Zhu, B | 1 |
| Baevsky, T; Dresner, J; Feldman, L; Kaiserman, I; Shani, M; Vinker, S | 1 |
| Bosco, AA; Lerario, AC; Santos, RF; Wajchenberg, BL | 1 |
| Araie, M; Iriyama, A; Kadowaki, T; Kubota, N; Muranaka, K; Tamaki, Y; Terauchi, Y; Usui, T; Yanagi, Y | 1 |
| Zhou, JY; Zhou, SW | 1 |
| Arrigoni, F; Costanza, F; Di Blasi, P; Longobardi, A; Merante, D; Tatti, P | 1 |
3 trial(s) available for rosiglitazone and Diabetic Retinopathy
| Article | Year |
|---|---|
Circulating adhesion molecules and associations with HbA1c, hypertension, nephropathy, and retinopathy in the Treatment Options for type 2 Diabetes in Adolescent and Youth study.
Topics: Adolescent; Age of Onset; Cell Adhesion Molecules; Child; Combined Modality Therapy; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Nephropathies; Diabetic Retinopathy; Drug Therapy, Combination; Female; Follow-Up Studies; Glycated Hemoglobin; Humans; Hypertension; Male; Metformin; Risk Reduction Behavior; Rosiglitazone | 2020 |
Effect of pioglitazone and rosiglitazone on mediators of endothelial dysfunction, markers of angiogenesis and inflammatory cytokines in type-2 diabetes.
Topics: Adult; Cholesterol, HDL; Cholesterol, LDL; Cholesterol, VLDL; Cytokines; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Diabetic Retinopathy; Endothelium, Vascular; Female; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Male; Middle Aged; Neovascularization, Pathologic; Patient Selection; Pioglitazone; PPAR gamma; Rosiglitazone; Thiazolidinediones; Triglycerides; Tumor Necrosis Factor-alpha; Vascular Endothelial Growth Factor A | 2009 |
Serum sialic acid changes in non-insulin-dependant diabetes mellitus (NIDDM) patients following bitter melon (Momordica charantia) and rosiglitazone (Avandia) treatment.
Topics: Adult; Blood Glucose; Cholesterol; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Female; Fruit; Humans; Hypoglycemic Agents; Hypolipidemic Agents; Male; Middle Aged; Momordica charantia; N-Acetylneuraminic Acid; Phytotherapy; Plant Preparations; Rosiglitazone; Thiazolidinediones; Triglycerides | 2009 |
16 other study(ies) available for rosiglitazone and Diabetic Retinopathy
| Article | Year |
|---|---|
Evolution of a 4-Benzyloxy-benzylamino Chemotype to Provide Efficacious, Potent, and Isoform Selective PPARĪ± Agonists as Leads for Retinal Disorders.
Topics: Animals; Benzylamines; Capillary Permeability; Cell Line; Diabetic Retinopathy; Disease Models, Animal; Drug Design; Drug Discovery; Humans; PPAR alpha; Rats; Retinal Diseases; Streptozocin | 2020 |
Combination therapy with semaglutide and rosiglitazone as a synergistic treatment for diabetic retinopathy in rodent animals.
Topics: Animals; Antioxidants; Cell Line; Cell Survival; Diabetic Retinopathy; Disease Models, Animal; Drug Therapy, Combination; Ependymoglial Cells; Glial Fibrillary Acidic Protein; Glucagon-Like Peptides; Humans; Inflammation; Male; Phosphatidylinositol 3-Kinases; Protective Agents; Proto-Oncogene Proteins c-akt; Rats, Sprague-Dawley; Rosiglitazone; Signal Transduction; TOR Serine-Threonine Kinases | 2021 |
Impact of thiazolidinediones on macular thickness and volume in diabetic eyes.
Topics: Blood Glucose; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Female; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Macular Edema; Male; Middle Aged; Pilot Projects; Pioglitazone; Prospective Studies; Retina; Rosiglitazone; Subretinal Fluid; Thiazolidinediones; Tomography, Optical Coherence; Visual Acuity | 2013 |
Rosiglitazone and delayed onset of proliferative diabetic retinopathy.
Topics: Aged; Angiogenesis Inhibitors; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Disease Progression; Female; Humans; Hypoglycemic Agents; Longitudinal Studies; Macular Edema; Male; Medical Records; Middle Aged; PPAR gamma; Retrospective Studies; Risk Reduction Behavior; Rosiglitazone; Thiazolidinediones; Visual Acuity | 2008 |
Spontaneous resolution of diabetic macular oedema after discontinuation of thiazolidenediones.
Topics: Diabetes Mellitus, Type 2; Diabetic Retinopathy; Humans; Hypoglycemic Agents; Macular Edema; Male; Middle Aged; Remission, Spontaneous; Rosiglitazone; Thiazolidinediones; Visual Acuity | 2008 |
Glitazone use associated with diabetic macular edema.
Topics: Adult; Databases, Factual; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Incidence; Macular Edema; Middle Aged; Pioglitazone; PPAR gamma; Prospective Studies; Risk Factors; Rosiglitazone; Thiazolidinediones | 2009 |
A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice.
Topics: 1-Acylglycerophosphocholine O-Acyltransferase; Acetyl Coenzyme A; Animals; Chlorocebus aethiops; Cloning, Molecular; COS Cells; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Disease Models, Animal; Hypoglycemic Agents; Lysophosphatidylcholines; Male; Mice; Platelet Activating Factor; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Rosiglitazone; Thiazolidinediones; Transfection | 2009 |
Thiazolidinediones reduce pathological neovascularization in ischemic retina via an adiponectin-dependent mechanism.
Topics: Adiponectin; AMP-Activated Protein Kinases; Animals; Diabetic Retinopathy; Hypoglycemic Agents; Ischemia; Mice; Mice, Inbred C57BL; Mice, Knockout; Neovascularization, Pathologic; Pioglitazone; Retinal Vessels; Rosiglitazone; Thiazolidinediones; Tumor Necrosis Factor-alpha | 2010 |
Association of proliferative diabetic retinopathy with insulin use and microalbuminuria.
Topics: Albuminuria; Angiogenesis Inhibitors; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Disease Progression; Humans; Hypoglycemic Agents; Insulin; Macular Edema; PPAR gamma; Rosiglitazone; Thiazolidinediones | 2010 |
[Diabetic edematous maculopathy associated with rosiglitazone treatment: report of a case].
Topics: Diabetes Mellitus, Type 2; Diabetic Retinopathy; Female; Humans; Hypoglycemic Agents; Macular Edema; Middle Aged; Rosiglitazone; Thiazolidinediones | 2009 |
Protective effects of rosiglitazone on retinal neuronal damage in diabetic rats.
Topics: Animals; Apoptosis; Blotting, Western; Caspase 3; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Hypoglycemic Agents; In Situ Nick-End Labeling; Male; Microscopy, Confocal; Neuroprotective Agents; Rats; Rats, Sprague-Dawley; Retinal Ganglion Cells; Rosiglitazone; STAT3 Transcription Factor; Suppressor of Cytokine Signaling 3 Protein; Suppressor of Cytokine Signaling Proteins; Thiazolidinediones | 2011 |
Is rosiglitazone use associated with an increase in intensive eye treatment in diabetic patients? A community based study.
Topics: Aged; Cohort Studies; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Female; Follow-Up Studies; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Laser Therapy; Lasers, Gas; Male; Middle Aged; Retrospective Studies; Rosiglitazone; Thiazolidinediones; Time Factors; Vitrectomy | 2011 |
Effect of thalidomide and rosiglitazone on the prevention of diabetic retinopathy in streptozotocin-induced diabetic rats.
Topics: Angiogenesis Inhibitors; Animals; Aqueous Humor; Capillaries; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Disease Models, Animal; Hypoglycemic Agents; Rats; Rats, Sprague-Dawley; Retinal Vessels; Rosiglitazone; Thalidomide; Thiazolidinediones; Vascular Endothelial Growth Factor A | 2003 |
Effects of peroxisome proliferator-activated receptor gamma and its ligand on blood-retinal barrier in a streptozotocin-induced diabetic model.
Topics: Animals; Blood Glucose; Blood-Retinal Barrier; Capillary Permeability; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Enzyme-Linked Immunosorbent Assay; Fluorophotometry; Immunoenzyme Techniques; Intercellular Adhesion Molecule-1; Leukocytes; Leukostasis; Ligands; Male; Mice; Mice, Inbred C57BL; PPAR gamma; Rats; Rats, Inbred BN; Retinal Vessels; Rosiglitazone; Thiazolidinediones; Tumor Necrosis Factor-alpha; Up-Regulation; Vascular Endothelial Growth Factor A | 2006 |
Effect of berberine on PPARalpha/delta/gamma expression in type 2 diabetic rat retinae.
Topics: Animals; Berberine; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Fenofibrate; Hypoglycemic Agents; Male; PPAR alpha; PPAR delta; PPAR gamma; Rats; Rats, Wistar; Retina; Rosiglitazone; Thiazolidinediones | 2007 |
Retrospective analysis of rosiglitazone and macular oedema in patients with type 2 diabetes mellitus.
Topics: Adult; Aged; Color Perception Tests; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Female; Fundus Oculi; Humans; Hypoglycemic Agents; Macular Edema; Male; Middle Aged; Retina; Retrospective Studies; Rosiglitazone; Thiazolidinediones; Vision Tests; Visual Acuity | 2008 |